CpG-conjugated apoptotic tumor cells elicit potent tumor-specific immunity.
CpG-conjugated apoptotic tumor cells elicit potent tumor-specific immunity.
复制标题
DOI:
10.1007/s00262-011-0973-y
复制
发表时间:
2011-05
期刊:
影响因子:
--
通讯作者:
Klinman DM
中科院分区:
文献类型:
--
作者:
Shirota H;Klinman DM
The primary goal of cancer immunotherapy is to elicit an immune response capable of eradicating established tumors and preventing tumor metastasis. One strategy to achieve this goal utilizes whole killed tumor cells as the primary immunogen. Killed tumor cells provide a comprehensive source of tumor-associated antigens (TAAs), thereby eliminating the need to identify individual antigens. Unfortunately, killed tumor cells tend to be poorly immunogenic. To overcome this limitation, we covalently conjugated immunostimulatory CpG oligodeoxynucleotides (ODN) to apoptotic tumor cells and examined their ability to induce TAA-specific immune responses. Results indicate that CpG conjugation enhances the uptake of cell-based vaccines by dendritic cells (DCs), up-regulates co-stimulatory molecule expression, and promotes the production of immunostimulatory cytokines. Vaccination with CpG-conjugated tumor cells triggers the expansion of tumor-specific cytotoxic T lymphocytes (CTL) that reduce the growth of established tumors and prevents their metastatic spread. Thus, conjugating CpG ODN to cell-based tumor vaccines is an important step toward improving cancer immunotherapy.
登录
查看更多内容
影响因子:
15.9
作者:
Coughlin, CM;Salhany, KE;Lee, WMF
通讯作者:
Lee, WMF
影响因子:
9.1
作者:
Cooper, CL;Davis, HL;Heathcote, J
通讯作者:
Heathcote, J
影响因子:
5.5
作者:
Halperin, SA;Van Nest, G;Eiden, JJ
通讯作者:
Eiden, JJ
影响因子:
64.8
作者:
Hemmi, H;Takeuchi, O;Akira, S
通讯作者:
Akira, S
影响因子:
3.9
作者:
Hofmann, Maja A.;Kors, Christian;Trefzer, Uwe
通讯作者:
Trefzer, Uwe